Kyungseon Choi, PharmD, PhD, MSc
he/him/his
Postdoctoral AssociateDownloadHi-Res Photo
Cards
Education
PhD
Kyung Hee University, Department of Regulatory Science / Pharmaceutical Economics, Big Data Analysis, & Policy (2025)
Kyung Hee University, Department of Regulatory Science / Pharmaceutical Economics, Big Data Analysis, & Policy (2025)
MSc
Pusan National University, College of Pharmacy / Pharmaceutical Economics, Outcomes Research, & Policy (2022)
Pusan National University, College of Pharmacy / Pharmaceutical Economics, Outcomes Research, & Policy (2022)
PharmD
Pusan National University, College of Pharmacy (2020)
Pusan National University, College of Pharmacy (2020)
About
Copy Link
Titles
Postdoctoral Associate
Biography
Dr. Kyungseon Choi is a Postdoctoral Associate at the Yale School of Medicine and the Center for Outcomes Research and Evaluation (CORE) at Yale New Haven Hospital. He holds Ph.D. and M.S. in Pharmaceutical Economics, Big Data Analysis, and Policy and a Pharm.D. from Pusan National University. His expertise lies in Health Economics, Outcomes Research (HEOR), and Health Policy, with a focus on epidemiology and economic evaluation. Dr. Choi is proficient in analyzing real-world data from sources like claims databases and electronic medical records. His dissertation utilized Bayesian causal inference to study the comparative effectiveness of treatments for diabetic macular edema using real-world data and randomized clinical trial data. Dr. Choi's achievements have been recognized with awards such as the Outstanding PhD Dissertation Award in Medicine and the Young Researcher Award in Regulatory Science.
Last Updated on September 02, 2025.
Departments & Organizations
Education & Training
- PhD
- Kyung Hee University, Department of Regulatory Science / Pharmaceutical Economics, Big Data Analysis, & Policy (2025)
- MSc
- Pusan National University, College of Pharmacy / Pharmaceutical Economics, Outcomes Research, & Policy (2022)
- PharmD
- Pusan National University, College of Pharmacy (2020)
Research
Copy Link
Overview
Public Health Interests
Cardiovascular Diseases; Chronic Diseases; Epidemiology Methods; Global Health; Health Economics; Health Insurance; Health Policy; Modeling; Bayesian Statistics; Pharmaceuticals and Medical Devices; Regulatory Affairs; Pharmacoepidemiology
ORCID
0000-0002-6616-6842
Research at a Glance
Yale Co-Authors
Frequent collaborators of Kyungseon Choi's published research.
Publications Timeline
A big-picture view of Kyungseon Choi's research output by year.
Erica Spatz, MD, MHS
Harlan Krumholz, MD, SM
Yuan Lu, ScD
14Publications
101Citations
Publications
2026
Single-Pill Combination Therapy for Hypertension Persistent Underuse in the United States, 2015-2025
Choi K, Kim C, Spatz E, Krumholz H, Lu Y. Single-Pill Combination Therapy for Hypertension Persistent Underuse in the United States, 2015-2025. Journal Of The American College Of Cardiology 2026 PMID: 42089854, DOI: 10.1016/j.jacc.2026.03.088.Peer-Reviewed Original ResearchAltmetric26-A-11791-ACC SINGLE-PILL COMBINATIONS FOR HYPERTENSION MANAGEMENT: WIDELY RECOMMENDED, RARELY USED
Choi K, Kim C, Spatz E, Krumholz H, Lu Y. 26-A-11791-ACC SINGLE-PILL COMBINATIONS FOR HYPERTENSION MANAGEMENT: WIDELY RECOMMENDED, RARELY USED. Journal Of The American College Of Cardiology 2026, 87: a301-a302. DOI: 10.1016/j.jacc.2026.02.746.Peer-Reviewed Original Research
2025
Impact of COVID-19 on disease-specific mortality, healthcare resource utilization, and disease burden across a population over 1 billion in 31 countries: an interrupted time-series analysis
Choi K, Jang M, Kim S, Park S, Suh H. Impact of COVID-19 on disease-specific mortality, healthcare resource utilization, and disease burden across a population over 1 billion in 31 countries: an interrupted time-series analysis. EClinicalMedicine 2025, 85: 103315. PMID: 40686673, PMCID: PMC12273489, DOI: 10.1016/j.eclinm.2025.103315.Peer-Reviewed Original ResearchCitationsAltmetricHealthcare Costs in HER2-Positive Metastatic Breast Cancer Patients under Third and Subsequent Line of Therapy
Jang M, Choi K, Suh H. Healthcare Costs in HER2-Positive Metastatic Breast Cancer Patients under Third and Subsequent Line of Therapy. Drug Targets And Therapeutics 2025, 4: 43-47. DOI: 10.58502/dtt.24.0021.Peer-Reviewed Original Research
2024
Patient-Centered Economic Burden of Diabetic Macular Edema: Retrospective Cohort Study
Choi K, Park S, Yoon H, Choi S, Mun Y, Kim S, Yoo S, Woo J, Park K, Na J, Suh H. Patient-Centered Economic Burden of Diabetic Macular Edema: Retrospective Cohort Study. JMIR Public Health And Surveillance 2024, 10: e56741. PMID: 39378098, PMCID: PMC11496919, DOI: 10.2196/56741.Peer-Reviewed Original ResearchCitationsAltmetricRWD29 Predictive Model for Dementia in Patients with Type 2 Diabetes Using a Common Data Model
Lee S, Choi K, Lee J, Suh H. RWD29 Predictive Model for Dementia in Patients with Type 2 Diabetes Using a Common Data Model. Value In Health 2024, 27: s362. DOI: 10.1016/j.jval.2024.03.1683.Peer-Reviewed Original Research
2023
Patient-Centered Economic Burden of Exudative Age-Related Macular Degeneration: Retrospective Cohort Study
Choi K, Park S, Han S, Mun Y, Lee D, Chang D, Kim S, Yoo S, Woo J, Park K, Suh H. Patient-Centered Economic Burden of Exudative Age-Related Macular Degeneration: Retrospective Cohort Study. JMIR Public Health And Surveillance 2023, 9: e49852. PMID: 38064251, PMCID: PMC10746973, DOI: 10.2196/49852.Peer-Reviewed Original ResearchCitationsAltmetricEPH231 The Impact of COVID-19 on National Disease Dynamics: Population-Based Interrupted Time Series Study in South Korea
Choi K, Kim S, Jang M, Park S, Suh H. EPH231 The Impact of COVID-19 on National Disease Dynamics: Population-Based Interrupted Time Series Study in South Korea. Value In Health 2023, 26: s245. DOI: 10.1016/j.jval.2023.09.1272.Peer-Reviewed Original ResearchEE244 Healthcare Resource Utilization and Costs in Patients with Alagille Syndrome Using Population-Based Healthcare Data from South Korea
Kim S, Choi K, Lee H, Suh H. EE244 Healthcare Resource Utilization and Costs in Patients with Alagille Syndrome Using Population-Based Healthcare Data from South Korea. Value In Health 2023, 26: s98. DOI: 10.1016/j.jval.2023.09.511.Peer-Reviewed Original ResearchEPH177 The Impact of COVID-19 on National Mortality: Population-Based Interrupted Time Series Study in South Korea
Suh H, Choi K, Kim S, Jang M, Park S. EPH177 The Impact of COVID-19 on National Mortality: Population-Based Interrupted Time Series Study in South Korea. Value In Health 2023, 26: s236. DOI: 10.1016/j.jval.2023.09.1219.Peer-Reviewed Original Research
News
Copy Link
Get In Touch
Copy Link